RD3L Activators encompass a diverse array of chemical compounds that enhance the functional activity of RD3L through various specific biochemical pathways. Forskolin, through its capacity to elevate intracellular cAMP levels, activates Protein Kinase A (PKA), which in turn influences the activity of RD3L via phosphorylation mechanisms. This cascade underscores the sensitivity of RD3L to cAMP-dependent signaling. Ionomycin, by increasing intracellular calcium levels, activates calcium/calmodulin-dependent protein kinase (CaMK), linking calcium signaling to the phosphorylation and consequent activation of RD3L. The use of Phorbol 12-myristate 13-acetate (PMA) exemplifies a different pathway, where the activation of Protein Kinase C (PKC) leads to a phosphorylation cascade that includes RD3L, highlighting its integration in PKC-mediated signaling. Additionally, Sildenafil, by inhibiting phosphodiesterase and thus preventing cAMP and cGMP breakdown, indirectly enhances RD3L's activity through sustained PKA signaling.
Further extending the scope of RD3L activation, compounds like Epigallocatechin gallate (EGCG) and LY294002 modulate kinase activity, influencing RD3L indirectly. EGCG inhibits certain kinases that otherwise negatively regulate RD3L, lifting these inhibitory effects and enhancing RD3L activity. LY294002, a PI3K inhibitor, alters downstream AKT signaling, which intersects with RD3L's functional pathways. The modulation of MAPK signaling through SB203580, a p38 inhibitor, and U0126, a MEK inhibitor, further demonstrates the nuanced regulation of RD3L, as these inhibitors shift the signaling balance towards pathways favoring RD3L activation. Curcumin and Resveratrol operate through NF-κB inhibition and SIRT1 activation, respectively, both leading to modifications in the signaling landscape that favor RD3L activation. Capsaicin's activation of TRPV1 channels results in calcium influx and subsequent activation of CaMK, once again linking to RD3L activation through calcium-dependent pathways. Lastly, Zinc Pyrithione's impact on metal ion homeostasis indirectly influences signaling pathways that activate RD3L. Together, these compounds represent a concerted and multifaceted approach to enhancing the activity of RD3L, each contributing through distinct but interconnected signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which activates Protein Kinase A (PKA). PKA then phosphorylates specific substrates, leading to the activation of RD3L, as RD3L is modulated by phosphorylation-dependent mechanisms. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin elevates intracellular calcium levels, activating calcium/calmodulin-dependent protein kinase (CaMK). CaMK then activates RD3L through phosphorylation, as RD3L activity is influenced by calcium-dependent signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate and activate RD3L. The activation of PKC leads to a cascade of phosphorylation events, ultimately enhancing RD3L's functional activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG, a kinase inhibitor, indirectly activates RD3L by inhibiting kinases that negatively regulate RD3L, thereby removing inhibitory constraints on RD3L's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly enhances RD3L function by altering downstream signaling pathways, such as AKT, which interact with RD3L signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580, a p38 MAPK inhibitor, indirectly activates RD3L by shifting the signaling balance towards pathways that upregulate RD3L's activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126, a MEK inhibitor, shifts the signaling equilibrium to favor pathways associated with RD3L, thus enhancing its functional activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin modulates various signaling pathways, including NF-κB, which is indirectly involved in RD3L activation. By inhibiting NF-κB, curcumin reduces the inhibition on pathways that lead to RD3L activation. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $94.00 $173.00 $255.00 $423.00 | 26 | |
Capsaicin activates transient receptor potential vanilloid 1 (TRPV1) channels, leading to calcium influx and the activation of CaMK, which in turn activates RD3L through calcium-dependent phosphorylation pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates SIRT1, a protein deacetylase. The activation of SIRT1 leads to the deacetylation of key proteins in pathways that activate RD3L, thus enhancing its activity. | ||||||